Merck & Co., Inc: all 2,453 studies
Page 20 of 25. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks (MK-2355-005)CompletedNCT01371604Phase 2
- A Bioequivalence Study of SCH 530348 2.5 mg Tablets (P06558)CompletedNCT01358344Phase 1
- ROTATEQ™ Post-Marketing Surveillance in the PhilippinesTerminatedNCT01357174
- GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)TerminatedNCT01355003
- A Open-label Study to Evaluate the Relative Bioavailability of Samatasvir (IDX184) and Food Effect in Healthy Male Participants (MK-2355-006)CompletedNCT01335607Phase 1
- Safety, Pharmacokinetics, and Pharmacodynamics of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003)CompletedNCT01329913Phase 1
- A Study to Evaluate the Use of an Indwelling Catheter to Obtain Cerebrospinal Fluid (CSF) by Low-rate Continuous Sampling (MK-0000-211)CompletedNCT01325662
- Assessment of the Disease Severity and Treatment Patterns of Rheumatoid Arthritis in Eastern Europe, Middle East and North African Countries (P08167)WithdrawnNCT01313871
- A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1)CompletedNCT01311882Phase 1
- Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049)CompletedNCT01295632Phase 1
- Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)CompletedNCT01294735Phase 1
- Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)WithdrawnNCT01293656
- A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077)CompletedNCT01293643Phase 3
- Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mgCompletedNCT01271998Phase 1
- A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636)TerminatedNCT01269658Phase 2
- A Study of Two Methodologies for Measuring Blood Flow in the Brain in Response to Non-Drug Stimuli (P08085/MK-0000-180)CompletedNCT01244282Phase 1
- Extension Study of ACE-031 in Subjects With Duchenne Muscular DystrophyTerminatedNCT01239758Phase 2
- A Study of Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3)CompletedNCT01234857Phase 2
- A Phase I Study of MK-4827 for Treatment of Solid Tumors (MK-4827-005)TerminatedNCT01226901Phase 1
- Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS MutationsCompletedNCT01225536Phase 1
- Evaluation of Pharmacokinetics, Safety, And Tolerability Of Ertugliflozin (PF-04971729, MK-8835) In Japanese And Western Healthy Participants (MK-8835-041)CompletedNCT01223339Phase 1
- The Growth Factor Signature (GFS) as an Intermediate Biomarker of Response for Development of PI3K-Pathway Inhibitors in Patients With Breast Cancer (MK-8669-050)CompletedNCT01220570Phase 1
- A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)TerminatedNCT01220258Phase 2
- Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)CompletedNCT01218360
- Bioavailability of Variably Aged MK-0974 Tablets (MK-0974-038)(COMPLETED)CompletedNCT01209741Phase 1
- Effects of Insomnia on Simulated Driving (MK-0000-183-00)CompletedNCT01209728Phase 1
- A Safety and Tolerability Study of Denufosol in 2-4 Year OldsCompletedNCT01181622Phase 2
- Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)CompletedNCT01181310Phase 1
- A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)CompletedNCT01174147
- A Drug-Drug Interaction Study Evaluating the Combination of IDX320 and IDX184 in Healthy Participants (MK-6844-002)CompletedNCT01157104Phase 1
- Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent PatientsCompletedNCT01156077Phase 1
- MK6186 in HIV-1 Infected Patients (MK-6186-007 AM2)TerminatedNCT01152255Phase 1
- Pharmacodynamic and Pharmacokinetic Variability of a Basal Insulin (0000-168)CompletedNCT01152242Phase 1
- Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451)WithdrawnNCT01148901Phase 4
- Development of Magnetic Resonance Spectroscopy (MRS) Biomarkers of Tumor Metabolism (MK-0000-145)CompletedNCT01138813
- A Radiolabeled Mass Balance Study of [14C]-Ertugliflozin (PF04971729, MK-8835) In Healthy Male Participants (MK-8835-038)CompletedNCT01127308Phase 1
- Pharmacokinetics of Anacetrapib (MK0859) in Subjects With Impaired Renal Function (MK-0859-038)CompletedNCT01122667Phase 1
- Effects of Pioglitazone on Insulin Sensitivity in Healthy Overweight and Obese Males (MK-0000-170)CompletedNCT01115712Phase 1
- Study To Estimate The Relative Bioavailability of Ertugliflozin (PF-04971729, MK-8835) in Healthy Adult Participants (MK-8835-039)CompletedNCT01114568Phase 1
- Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039)CompletedNCT01114490Phase 1
- EEG (Electroencephalogram) Platform Standardization in Healthy Male Subjects (3134-010)CompletedNCT01110616Phase 1
- Study of Magnetic Resonance Imaging (MRI) to Quantify Liver Fat in Diabetic and Pre-Diabetic Patients (0000-171)CompletedNCT01110577
- Reproducibility and Comparison of Platelet Function Assays With Aspirin and Clopidogrel (MK-0000-167)CompletedNCT01108588Phase 1
- A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE)CompletedNCT01105624Phase 4
- A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093)CompletedNCT01104519Phase 1
- A Study of the Kinetics of a 13C-Cholesterol Infusate in Healthy Male Subjects (0000-108)(COMPLETED)CompletedNCT01101763
- Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)CompletedNCT01081158Phase 1
- Effect of Ridaforolimus on the Pharmacokinetics of Midazolam (Study MK-8669-044)CompletedNCT01071304Phase 1
- Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069)CompletedNCT01071291Phase 1
- A Study of MK2206 in Locally Advanced or Metastatic Solid Tumors (2206-007)CompletedNCT01071018Phase 1
- A Study of ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy RegimenWithdrawnNCT01070290Phase 2
- Two-Part Study to Evaluate the Dose Response of SCH 527123 on Sputum Neutrophilia Following Ozone Challenge in Healthy Subjects and Chronic Obstructive Pulmonary Disease (COPD) Patients (P05567 AM7)TerminatedNCT01068145Phase 1
- Stocrin Re-examination Study (0831-028)CompletedNCT01065792
- Januvia Re-examination Study (MK-0431-181)CompletedNCT01062048
- A Study That Will Evaluate Ketogenesis and Glucose-Dependent Insulin Secretion Methodologies in Healthy Male Subjects (MK-0000-159)(COMPLETED)CompletedNCT01055340Phase 1
- A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)TerminatedNCT01050283Phase 1
- Ridaforolimus in Patients With Hepatic Insufficiency (MK-8669-046)CompletedNCT01043887Phase 1
- Isentress Re-examination Study (MK-0518-115)CompletedNCT01042808
- A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED)CompletedNCT01033318Phase 1
- A Study to Assess the Effects of Exenatide on Insulin Secretion Rates Using a Graded Infusion of Intravenous Glucose (0000-099)(COMPLETED)CompletedNCT01021527Phase 1
- A Study to Evaluate the Use of a Graded Infusion of Intravenous Glucose in the Assessment of Insulin Secretion Rates (MK-0000-078)CompletedNCT01021462Phase 1
- Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic AntibioticsCompletedNCT01019395Phase 1
- A Multiple Dose Study Of Ertugliflozin (PF-04971729, MK-8835) In Otherwise Healthy Overweight And Obese Volunteers (MK-8835-037)CompletedNCT01018823Phase 1
- Safety and Tolerability of MK0773 in Healthy Older Men (0773-004)CompletedNCT01017458Phase 1
- A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye DiseaseCompletedNCT01014078Phase 4
- Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003)CompletedNCT01011725Phase 1
- Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004)CompletedNCT01011166Phase 2
- Phase II Study of Ridaforolimus (MK-8669) With Metastatic Bone or Soft-tissue Sarcoma Patients (MK-8669-030 AM1)CompletedNCT01010672Phase 2
- Study of SCH 527123 in Subjects With Severe Asthma (Study P05109AM1)WithdrawnNCT01006161Phase 2
- A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)WithdrawnNCT01003431Phase 3
- Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple MyelomaCompletedNCT00996957Phase 1
- Analgesic Efficacy and Safety of ADL5859 in Subjects With Acute Dental Pain After Third Molar ExtractionCompletedNCT00993863Phase 2
- The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)CompletedNCT00990808Phase 1
- A Single Escalating Dose Study Of Ertugliflozin (PF-04971729, MK-8835) Under Fed and Fasted Conditons In Healthy Volunteers (MK-8835-036)CompletedNCT00989079Phase 1
- Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic TherapyCompletedNCT00988741Phase 2
- Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN)WithdrawnNCT00988728Phase 2
- Study of Efficacy, Pharmacokinetics and Safety of Continuous Intravenous Infusion of Org 9426 (Study P05977)CompletedNCT00988520Phase 3
- Study of Efficacy, Pharmacokinetics, and Safety of Bolus Maintenance Doses of Org 9426 (Study P05976)(COMPLETED)CompletedNCT00984633Phase 3
- Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)CompletedNCT00983255Phase 1
- A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)CompletedNCT00977288Phase 2
- A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)CompletedNCT00975052Phase 1
- Biomarkers of Prednisolone Treatment (P05888)CompletedNCT00971724Not applicable
- Comparative Study of Rocuronium With Vecuronium (Study 71101)(COMPLETED)CompletedNCT00970762Phase 3
- A Study to Investigate Biomarkers of Skin Androgenization Following Testosterone Administration (0000-015)(COMPLETED).CompletedNCT00969163Phase 1
- Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042)CompletedNCT00966030Phase 1
- Bioequivalence of Two Tablet Forms of MK0974 (0974-045)CompletedNCT00965887Phase 1
- Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428)CompletedNCT00963573Phase 4
- A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048)CompletedNCT00961857Phase 1
- A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095)CompletedNCT00961480Phase 1
- Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)CompletedNCT00959582Phase 1
- Gut Hormone Profiling in Obese Patients With Type 2 Diabetes (MK-0000-134)CompletedNCT00957957
- A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 in Healthy Postmenopausal WomenCompletedNCT00952887Phase 1
- A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)TerminatedNCT00943371Phase 1
- Study of the Effect of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability (2637-008)CompletedNCT00934466Phase 1
- Study to Evaluate ATP-induced Pain and ATP-induced Dermal Vasodilation by Iontophoresis (0000-118)(COMPLETED)CompletedNCT00917696Phase 1
- A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103)CompletedNCT00914212Phase 1
- Protocol for Eslax Intravenous Drug Use Investigation (Study P06082)CompletedNCT00902070
- Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)WithdrawnNCT00895882Phase 2
- The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638)CompletedNCT00894530Phase 2
- A Study of Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine (V520-019)CompletedNCT00894114Phase 1